Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CG Oncology (CGON) Equity Average (2024 - 2025)

Historic Equity Average for CG Oncology (CGON) over the last 2 years, with Q3 2025 value amounting to $679.0 million.

  • CG Oncology's Equity Average rose 2468.69% to $679.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $679.0 million, marking a year-over-year increase of 2468.69%. This contributed to the annual value of $305.1 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that CG Oncology reported Equity Average of $679.0 million as of Q3 2025, which was up 2468.69% from $687.6 million recorded in Q2 2025.
  • In the past 5 years, CG Oncology's Equity Average ranged from a high of $719.1 million in Q1 2025 and a low of $222.9 million during Q1 2024